Maxcyte (MXCT) Current Assets (2020 - 2026)

Maxcyte (MXCT) has 7 years of Current Assets data on file, last reported at $122.9 million in Q1 2026.

• On a quarterly basis, Current Assets fell 21.07% year-over-year to $122.9 million in Q1 2026; TTM through Mar 2026 was $122.9 million, a 21.07% decrease from a year earlier, with the FY2025 full-year figure at $118.4 million, down 31.05% from the prior year.
• Current Assets for Q1 2026 stood at $122.9 million, up from $118.4 million in the prior quarter.
• Over the last five years, Current Assets for MXCT reached as high as $265.8 million in Q1 2022 and fell as low as $118.4 million in Q4 2025.
• Historically, Current Assets has averaged $192.9 million across 5 years, with a median of $178.7 million in 2024.
• Across the five-year window, Current Assets surged 204.67% in 2022 and tumbled 31.05% in 2025, its largest moves.
• Year by year, Current Assets stood at $252.3 million in 2022, then slipped by 24.61% to $190.2 million in 2023, then decreased by 9.73% to $171.7 million in 2024, then tumbled by 31.05% to $118.4 million in 2025, then climbed by 3.86% to $122.9 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $122.9 million in Q1 2026, $118.4 million in Q4 2025, and $124.6 million in Q3 2025.